JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on October 13, 2003; DOI: 10.1124/jpet.103.056135


0022-3565/03/3073-1112-1119$20.00
JPET 307:1112-1119, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.056135v1
307/3/1112    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Siccardi, D.
Right arrow Articles by McGuigan, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Siccardi, D.
Right arrow Articles by McGuigan, C.

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Stereoselective and Concentration-Dependent Polarized Epithelial Permeability of a Series of Phosphoramidate Triester Prodrugs of d4T: An in Vitro Study in Caco-2 and Madin-Darby Canine Kidney Cell Monolayers

Dario Siccardi, Lana E. Kandalaft, Mark Gumbleton, and Christopher McGuigan

Medicinal Chemistry Group (D.S., C.M.) and Pharmaceutical Cell Biology Group (L.E.K., M.G.), Welsh School of Pharmacy, Cardiff University, Cardiff, Wales

Nucleoside analogs are successful, widely used antiviral and anticancer therapeutics. Nucleotide prodrugs (i.e., pronucleotide) have increasingly been used to improve in vivo efficacy of nucleoside analogs. In this study, we evaluated the permeability of a series of phosphoramidate triester prodrugs of the anti-HIV drug 2',3'-didehydro-2',3'-dideoxythymidine across monolayers of Caco-2, Madin-Darby canine kidney (MDCKII) epithelial cell line, and its recombinant clone containing the human MDR1/P-gp gene (MDR1-MDCKII). Transport was studied in the apical-to-basolateral (A-B) and the basolateral-to-apical directions (B-A). The impact upon transport of differences in stereochemistry at the chiral phosphate center was evaluated. In the Caco-2 and MDCK models the A-B permeability was lower than expected based on the lipophilicity of the compounds, suggesting the involvement of a polarized efflux system and/or metabolic degradation in limiting the absorption of these ester-based prodrugs. Average permeability values through cell monolayers obtained in the A-B direction were lower than in the B-A direction. The inclusion of the P-glycoprotein (P-gp) inhibitor verapamil in the transport medium markedly increased the permeability in the A-B direction, whereas decreasing it in the opposite direction, suggesting an efflux mechanism mainly mediated by P-gp. Stereoselective permeability was significant for the most lipophilic compounds, where the diastereoisomer possessing the slower eluting time on a reverse-phase high-performance liquid chromatography column was transported through Caco-2 and MDCK monolayers at higher rate.


Received June 25, 2003; accepted September 2, 2003.

Address correspondence to: Christopher McGuigan, Welsh School of Pharmacy, University of Wales Cardiff, King Edward VII Ave., Cardiff CF10 3XF, Wales. E-mail: mcguigan{at}cf.ac.uk




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
J. Cao, X. Chen, J. Liang, X.-Q. Yu, A.-L. Xu, E. Chan, D. Wei, M. Huang, J.-Y. Wen, X.-Y. Yu, et al.
Role of P-glycoprotein in the Intestinal Absorption of Glabridin, an Active Flavonoid from the Root of Glycyrrhiza glabra
Drug Metab. Dispos., April 1, 2007; 35(4): 539 - 553.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Zhang, M. Huang, S. Guan, H.-C. Bi, Y. Pan, W. Duan, S. Y. Chan, X. Chen, Y.-H. Hong, J.-S. Bian, et al.
A Mechanistic Study of the Intestinal Absorption of Cryptotanshinone, the Major Active Constituent of Salvia miltiorrhiza
J. Pharmacol. Exp. Ther., June 1, 2006; 317(3): 1285 - 1294.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. L. Lorenzi, C. P. Landowski, X. Song, K. Z. Borysko, J. M. Breitenbach, J. S. Kim, J. M. Hilfinger, L. B. Townsend, J. C. Drach, and G. L. Amidon
Amino Acid Ester Prodrugs of 2-Bromo-5,6-dichloro-1-({beta}-D-ribofuranosyl)benzimidazole Enhance Metabolic Stability in Vitro and in Vivo
J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 883 - 890.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.